NEWARK, Calif., April 26, 2018 /PRNewswire/ -- Neodyne Biosciences, Inc. today announced they are partnering with professional tennis champion Serena Williams to raise awareness for its embrace® Active Scar Defense, an FDA cleared scar therapy system designed to prevent the formation of scar tissue before it forms visible and uncomfortable scars. Williams had both an unplanned C-section and emergency surgery following the birth of her baby girl, Olympia. She successfully used embrace to manage the pain and discomfort associated with her recovery and to significantly improve the appearance of her scar.